There have been 50 recent insider transactions recorded for Indaptus Therapeutics, Inc. (INDP), including 39 buys and 2 sells. Total insider buying was valued at $2.81M and total insider selling at $100.73K.
Notable insiders with recent activity include Lazar David E., Dai Junyi, Yao Yun. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — INDP
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-23 |
Lazar David E. |
Director |
Informative Sell |
700,000 |
- |
- |
- |
| 2026-03-23 |
Dai Junyi |
Chief Executive Officer |
Unknown |
- |
- |
- |
11,250,000 |
| 2026-03-23 |
Yao Yun |
10 Percent Owner |
Unknown |
- |
- |
- |
41,991,000 |
| 2026-03-23 |
Sino Lion Ventures Ltd |
10 Percent Owner |
Unknown |
- |
- |
- |
38,895,000 |
| 2026-02-26 |
Mcmurdo Matthew Charles |
Director |
Unknown |
- |
- |
- |
25,000 |
| 2026-02-26 |
Jabbour Jerome D |
Director |
Unknown |
- |
- |
- |
- |
| 2026-02-26 |
Jabbour Jerome D |
Director |
RSU Award |
25,000 |
$2.06 |
$51.5K |
25,000 |
| 2026-02-11 |
Meckler Jeffrey A |
Co-chief Executive Officer |
Return of Shares |
12,136 |
$8.30 |
$100.73K |
- |
| 2026-01-20 |
Ben-tzvi Avraham |
Director |
RSU Award |
25,000 |
- |
- |
25,100 |
| 2026-01-08 |
Natan David |
Director |
Unknown |
- |
- |
- |
- |
| 2026-01-07 |
Natan David |
Director |
RSU Award |
25,000 |
$2.69 |
$67.25K |
25,000 |
| 2025-12-23 |
Ben-tzvi Avraham |
Director |
RSU Award |
25,000 |
$1.95 |
$48.75K |
25,000 |
| 2025-12-22 |
Lazar David E. |
Co-chief Executive Officer |
Unknown |
- |
- |
- |
- |
| 2025-12-22 |
Ben-tzvi Avraham |
Director |
Unknown |
- |
- |
- |
100 |
| 2025-12-22 |
Meckler Jeffrey A |
10 Percent Owner, Officer: Co-chief Executive Officer |
RSU Award |
216,617 |
$2.03 |
$439.73K |
229,929 |
| 2025-12-22 |
Linscott Walt Addison |
Chief Operating Officer |
RSU Award |
54,421 |
$2.03 |
$110.47K |
54,426 |
| 2025-12-22 |
Sassi Nir |
Chief Financial Officer |
RSU Award |
26,758 |
$2.03 |
$54.32K |
26,758 |
| 2025-12-22 |
Newman Michael James |
CSO and Director |
RSU Award |
52,204 |
$2.03 |
$105.97K |
101,074 |
| 2025-07-27 |
Meckler Jeffrey A |
Chief Executive Officer |
RSU Award |
6,068 |
$8.30 |
$50.38K |
13,312 |
| 2025-06-10 |
Hayes William B |
Director |
RSU Award |
12,500 |
$0.33 |
$4.13K |
12,500 |
| 2025-06-10 |
Martell Robert |
Director |
RSU Award |
12,500 |
$0.33 |
$4.13K |
12,500 |
| 2025-06-10 |
Maddaluna Anthony J |
Director |
RSU Award |
12,500 |
$0.33 |
$4.13K |
12,500 |
| 2025-06-10 |
Pomerantz Roger |
Director |
RSU Award |
30,000 |
$0.33 |
$9.9K |
30,000 |
| 2025-06-10 |
Karah Hila |
Director |
RSU Award |
12,500 |
$0.33 |
$4.13K |
12,500 |
| 2025-06-10 |
Gilbert Mark John |
Director |
RSU Award |
12,500 |
$0.33 |
$4.13K |
12,500 |
| 2024-11-25 |
Meckler Jeffrey A |
CEO and Director |
RSU Award |
42,553 |
$1.05 |
$44.68K |
42,553 |
| 2024-10-09 |
Meckler Jeffrey A |
CEO and Director |
RSU Award |
75,000 |
$1.11 |
$82.88K |
75,000 |
| 2024-10-09 |
Linscott Walt Addison |
Chief Operating Officer |
RSU Award |
75,000 |
$1.11 |
$82.88K |
75,000 |
| 2024-10-09 |
Waltzman Roger J. |
Chief Medical Officer |
RSU Award |
75,000 |
$1.11 |
$82.88K |
75,000 |
| 2024-10-09 |
Sassi Nir |
Chief Financial Officer |
RSU Award |
75,000 |
$1.11 |
$82.88K |
75,000 |
| 2024-10-09 |
Newman Michael James |
10 Percent Owner, Officer: CSO and Director |
RSU Award |
75,000 |
$1.11 |
$82.88K |
75,000 |
| 2024-08-08 |
Meckler Jeffrey A |
CEO and Director |
RSU Award |
84,932 |
$1.70 |
$144.38K |
84,932 |
| 2024-06-06 |
Hayes William B |
Director |
RSU Award |
12,500 |
$2.63 |
$32.88K |
12,500 |
| 2024-06-06 |
Martell Robert |
Director |
RSU Award |
12,500 |
$2.63 |
$32.88K |
12,500 |
| 2024-06-06 |
Maddaluna Anthony J |
Director |
RSU Award |
12,500 |
$2.63 |
$32.88K |
12,500 |
| 2024-06-06 |
Pomerantz Roger |
Director |
RSU Award |
30,000 |
$2.63 |
$78.9K |
30,000 |
| 2024-06-06 |
Karah Hila |
Director |
RSU Award |
12,500 |
$2.63 |
$32.88K |
12,500 |
| 2024-06-06 |
Gilbert Mark John |
Director |
RSU Award |
12,500 |
$2.63 |
$32.88K |
12,500 |
| 2024-01-22 |
Meckler Jeffrey A |
CEO and Director |
RSU Award |
100,000 |
$1.74 |
$174K |
100,000 |
| 2024-01-22 |
Linscott Walt Addison |
Chief Operating Officer |
RSU Award |
75,000 |
$1.74 |
$130.5K |
75,000 |
| 2024-01-22 |
Waltzman Roger J. |
Chief Medical Officer |
RSU Award |
75,000 |
$1.74 |
$130.5K |
75,000 |
| 2024-01-22 |
Sassi Nir |
Chief Financial Officer |
RSU Award |
40,000 |
$1.74 |
$69.6K |
40,000 |
| 2024-01-22 |
Newman Michael James |
10 Percent Owner, Officer: CSO and Director |
RSU Award |
43,250 |
$1.74 |
$75.26K |
43,250 |
| 2023-08-14 |
Anderson Glen R. |
10 Percent Owner |
Informative Buy |
23,934 |
$2.34 |
$56.01K |
1,190,400 |
| 2023-08-11 |
Anderson Glen R. |
10 Percent Owner |
Informative Buy |
35,064 |
$2.12 |
$74.34K |
1,166,466 |
| 2023-08-10 |
Anderson Glen R. |
10 Percent Owner |
Informative Buy |
44,354 |
$1.94 |
$86.05K |
1,131,402 |
| 2023-08-07 |
Waltzman Roger J. |
Officer |
Unknown |
- |
- |
- |
- |
| 2023-08-07 |
Waltzman Roger J. |
Chief Medical Officer |
RSU Award |
90,000 |
$1.85 |
$166.5K |
90,000 |
| 2023-05-25 |
Hayes William B |
Director |
RSU Award |
12,500 |
$1.82 |
$22.75K |
12,500 |
| 2023-05-25 |
Maddaluna Anthony J |
Director |
RSU Award |
12,500 |
$1.82 |
$22.75K |
12,500 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
